Author: Craig Boerner
Jul. 31, 2012—A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.
Jul. 12, 2012—Researchers at Vanderbilt University Medical Center are leading an international clinical trial to examine the functional benefits of a combined therapy to treat acute ischemic stroke.
Jun. 15, 2012—Nonsupportive family members contribute to poor adherence to medication regimens and lower glycemic control in adults with diabetes.
Jun. 12, 2012—Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card.
Jan. 5, 2012—A new Vanderbilt study shows that the over-the-counter supplement melatonin is promising in helping children with autism spectrum disorders (ASD), and their families, sleep better. The study, published in the Journal of Autism and Developmental Disorders, contributes to the growing literature on supplemental melatonin for insomnia in ASD, according to lead author Beth Malow, M.D.,...
Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Jul. 20, 2011—A Vanderbilt study of U.S. soldiers returning from the wars in Iraq and Afghanistan shows a serious lung condition linked to prolonged exposures to sulfur fires and burn pits.
Apr. 4, 2011—Although an evaluation of existing treatments for children with autism spectrum disorders found positive results in some studies, better information is needed to target the right treatments to specific children.